Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108782914 | 10878291 | 4 | F | 20150217 | 20160819 | 20150302 | 20160824 | EXP | US-PFIZER INC-2015070988 | PFIZER | 72.00 | YR | M | Y | 0.00000 | 20160824 | CN | US | SG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108782914 | 10878291 | 1 | PS | LYRICA | PREGABALIN | 1 | 50 MG, UNK | U | 21446 | 50 | MG | CAPSULE, HARD | |||||||
| 108782914 | 10878291 | 2 | SS | LYRICA | PREGABALIN | 1 | 150 MG, 2X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | BID | ||||||
| 108782914 | 10878291 | 3 | SS | LYRICA | PREGABALIN | 1 | 200 MG, 2X/DAY | U | L00636 | 21446 | 200 | MG | CAPSULE, HARD | BID | |||||
| 108782914 | 10878291 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 3X/DAY | U | 21446 | 75 | MG | CAPSULE, HARD | TID | |||||
| 108782914 | 10878291 | 5 | C | HYDROCODONE W/ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 7.5 MG HYDROCODONE BITARTRATE, 325 MG PARACETAMOL, TWICE A DAY | 0 | BID | ||||||||||
| 108782914 | 10878291 | 6 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 108782914 | 10878291 | 7 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 130 MG, UNK | 0 | 130 | MG | |||||||||
| 108782914 | 10878291 | 8 | C | LISINOPRIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | 25 MG HYDROCHLOROTHIAZIDE, 20MG LISINOPRIL | 0 | |||||||||||
| 108782914 | 10878291 | 9 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | 50 MG, UNK | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108782914 | 10878291 | 1 | Pain |
| 108782914 | 10878291 | 2 | Neuropathy peripheral |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108782914 | 10878291 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108782914 | 10878291 | Ankle fracture | |
| 108782914 | 10878291 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108782914 | 10878291 | 1 | 201403 | 0 | ||
| 108782914 | 10878291 | 3 | 201503 | 0 | ||
| 108782914 | 10878291 | 6 | 201408 | 0 | ||
| 108782914 | 10878291 | 7 | 201408 | 0 | ||
| 108782914 | 10878291 | 8 | 2010 | 0 | ||
| 108782914 | 10878291 | 9 | 201403 | 0 |